Generali Investments Towarzystwo Funduszy Inwestycyjnych Beam Therapeutics Inc. Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $192 Billion
- Q2 2025
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 51,000 shares of BEAM stock, worth $1.29 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
51,000
Previous 45,000
13.33%
Holding current value
$1.29 Million
Previous $879 Million
1.29%
% of portfolio
0.45%
Previous 0.56%
Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
245Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$254 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$246 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$225 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$194 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$120 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.79B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...